Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 5 hours agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 1 day agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 8 hours agoThe company usually earns collaboration revenues from agreements with several big pharma/biotech...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 17 hours agoLast year, major pharmaceutical companies heavily invested in R&D, with expenditure ranging from around 14% to 50% of their revenues. Some of the...
Merck stock target raised on strong Q1 results By Investing.com
Investing.com· 6 days agoOn Friday, Wells Fargo adjusted its outlook on shares of pharmaceutical giant Merck & Co., Inc....
Merck KGaA's Dividend Analysis
GuruFocus.com via Yahoo Finance· 4 days agoMerck KGaA (MKKGY) recently announced a dividend of $0.47 per share, payable on 2024-05-09, with the ex-dividend date set for 2024-04-29. As investors...
Cantor Fitzgerald Brokers Boost Earnings Estimates for Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 3 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) – Equities research analysts at Cantor Fitzgerald increased their FY2024 earnings per share (EPS) estimates for shares of
Merck reports promising V116 vaccine trial results By Investing.com
Investing.com· 3 days agoMerck & Co. (NYSE: MRK) has presented new data from its Phase 3 STRIDE-10 trial of V116, an...
MilliporeSigma invests in new life science site in South Korea
Homenewshere.com· 4 hours agoMilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, invests more than €300 million into a new Bioprocessing Production Center in Daejeon ...
Corcept (CORT) Q1 Earnings & Revenues Surpass Estimates
Zacks via Yahoo Finance· 8 hours agoMeanwhile, a phase Ib study is evaluating relacorilant in combination with Merck’s PD-1 checkpoint...